Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

NCT03872401 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

12301

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Heart Disease (CHD)

Interventions

DRUG: Evolocumab
DRUG: Placebo

Sponsor

Amgen